Group 1: Hong Kong Stocks - Ascentage Pharma-B (06855) opened over 5% higher after receiving FDA and EMA approval for its drug, Lisenglitazone, for high-risk MDS in Phase III clinical trials [1] - Haijia Medical (06078) fell over 5% following a profit warning, expecting a mid-term net profit decline of approximately 34% to 39% due to factors like centralized procurement and increased depreciation from new hospitals [1] - Hua Hong Semiconductor (01347) dropped over 6% as it announced plans to acquire a controlling stake in Shanghai Huali Microelectronics to address industry competition [1] - Zhonghui Biotech-B (02627) rose over 8% after receiving IND approval for its recombinant respiratory syncytial virus vaccine in both the US and China [1] - NetDragon (00777) surged over 10% after forming a strategic alliance with Zhongke Wenge to promote AI technologies abroad [1] - Great Wall Motors (02333) increased over 12% following the completion of its factory in Brazil, with an initial production capacity of 30,000 vehicles per year [1] - Yuewen Group (00772) rose over 20% as its first-half performance exceeded expectations, benefiting from growth in licensing business and steady performance of short dramas [1] Group 2: Other Notable Stocks - Huirui Group (00806) increased over 8% after reporting first-half results that met market expectations and is applying for MRF mutual recognition for other products [2] - Soundon Technology (02495) surged nearly 30% after announcing a projected net profit exceeding 50 million yuan for the first half, marking a turnaround from losses [2] - Robotics concept stocks saw significant gains, with Jinshang Machine Tool (01651) up over 11% and Lijin Technology (00558) up over 3% [2] Group 3: US Stocks - Intel (INTC.US) rose 2.93% amid reports of negotiations with the Trump administration for government investment to support domestic manufacturing [3] - Hesai Technology (HSAI.US) increased 9.73% after reporting over 50% year-on-year revenue growth for Q2 2025 [3] - UnitedHealth (UNH.US) surged 11.98% following Berkshire Hathaway's new investments in the company [3] - NIO (NIO.N) rose 8.09% as it announced the upcoming launch of its new ES8 model [4] - Xunlei (XNET.US) continued to rise by 26.53% after reporting a 30.6% year-on-year revenue increase for Q2 2025 [5]

Core Viewpoint - NetDragon (00777) has seen a stock increase of over 7%, currently at 12.48 HKD, with a trading volume of 22.21 million HKD, following the announcement of a strategic alliance aimed at promoting AI technology in enterprise and education sectors [1] Group 1: Strategic Alliance - NetDragon and its subsidiary Cherrypicks have formed a strategic alliance with Zhongke Wenge to lead the future of AI mobile intelligence [1] - The collaboration will focus on exclusive cooperation outside mainland China to promote AI services [1] - Cherrypicks will serve as the sole overseas platform and commercialization partner for Zhongke Wenge in international markets [1] Group 2: Investment and Resource Allocation - Zhongke Wenge will invest in Cherrypicks and provide AI technology resources to support joint product development and solutions targeting overseas markets in sectors such as public services, finance, healthcare, and commerce [1] Group 3: Market Positioning and Impact - The collaboration is seen as a model for the integration of Chinese AI technology and Hong Kong's innovation capabilities [1] - Cherrypicks aims to act as a bridge between mainland and international markets, leveraging synergies to promote advanced AI technologies like the "Yayi" model in Hong Kong and abroad [1] - This initiative is expected to enhance Hong Kong's development as an international innovation and technology hub [1]